Chapter 1 : A Primer on Xenotransplantation

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

A Primer on Xenotransplantation, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap01-2.gif


No area of medicine stimulates as much excitement or as much controversy as transplantation. The rationale for xenotransplantation is the shortage of human organs and tissues. For several reasons, however, most in the field of xenotransplantation have abandoned the use of nonhuman primates. Therefore, instead of using primates, most in the field of transplantation focus on the use of pigs or other non-primate species. If opportunities offered by xenotransplantation are great, the hurdles, at present, appear equally so. These hurdles include (i) the immune response of the host against the graft leading to rejection of the graft, (ii) the inherent physiologic limitations of the animal tissue or organ in a human system or induced disruption of the normal functions of the recipient, and (iii) the possibility of transferring infectious agents from the transplant to the recipient and, potentially, more broadly to the general population. This chapter focuses on the hurdles to transplanting porcine organs and cells into humans. The past few years have brought significant progress in defining the hurdles to xenotransplantation and progress in overcoming the immunologic and physiologic hurdles in this field.

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

The immunological responses to xenotransplantation of various tissue types. Xenografts of free tissues such as pancreatic islets or isolated cells such as bone marrow cells are subject to early failure due to primary non-function, failure to neovascularize, or molecular incompatibilities and subsequent cell-mediated rejection. A porcine organ transplanted into a human would be subject to one or more of the immunological reactions shown here. Transplantation into an untreated recipient would give rise to hyperacute rejection. If hyperacute rejection is avoided, for example, by the inhibition of complement, the graft is subjected to acute vascular rejection. If anti-donor antibodies are depleted from the recipient, the graft may undergo accommodation, a condition in which acute vascular rejection does not occur despite the presence of anti-donor antibodies in the circulation of the recipient. If acute vascular rejection is avoided, the graft will undergo cell-mediated rejection or chronic rejection.

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Possible ways in which Galαl-3Gal expression could be decreased by genetic engineering. Synthesis of Gal1-3Gal is catalyzed by 1,3-galactosyltransferase (GT); the biosynthetic pathway is shown by dashed arrows. This enzyme adds galactose residues at the termini of oligosaccharide chains. Four possible approaches to preventing the synthesis of the sugar are shown by normal arrows. First, the expression of antisense RNA or a ribozyme might disrupt the structure or function of the GT mRNA. Second, introduction of a gene for an inhibitory ligand for GT, such as an appropriate Fv (an antibody-like molecule) or an aptamer (a small oligonucleotide inhibitor), might inhibit the function of the enzyme. Third, overexpression of another glycosyl transferase, such as H transferase, which adds fucose residues, might compete for the subterminal residues on oligosaccharide chains. This has been achieved in rats by the overexpression of a human H transferase, resulting in the addition of fucose rather than Gal1-3Ga1 to oligosaccharide side chains ( ). Fourth, expression of a glycosidase, such as a-galactosidase, might lead to cleavage of the antigenic saccharide chains. Reprinted by permission from 392(Suppl.):l 1-17, 1998, Macmillan Magazines Ltd.

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Akhter, S. A.,, C. A. Skaer,, A. P. Kypson,, P. H. McDonald,, K. C. Peppel,, D. D. Glower,, R. J. Lefkowitz,, and W. J. Koch. 1997. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Nat. Acad. Sci. USA 94: 12100 12105.
2. Alexandre, G. P. J.,, P. Gianello,, D. Latinne,, M. Carlier,, A. Dewaele,, L. Van Obbergh,, M. Moriau,, E. Marbaix,, J. L. Lambotte,, L. Lambotte,, and J. P. Squifflet,. 1989. Plasmapheresis and splenectomy in experimental renal xenotransplantation, p. 259 266. In M. A. Hardy (ed.), Xenograft 25. Elsevier Science Publishers, New York, N.Y.
3. Alvarado, C. G.,, A. H. Cotterell,, K. R. McCurry,, B. H. Collins,, J. C. Magee,, J. Berthold,, J. S. Logan,, and J. L. Platt. 1995. Variation in the level of xenoantigen expression in porcine organs. Transplantation 59: 1589 1596.
4.Anonymous. November 14, 1911. Dr. Hammond gives patient new kidney. The New York Times, New York, N.Y.
5.Anonymous. November 15, 1911. A new surgical feat. The New York Times, New York, N.Y.
6. Atkinson, J. P.,, T. J. Oglesby,, D. White,, E. A. Adams,, and M. K. Liszewski. 1991. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor. Clin. Exp. Immunol. 86( Supp. l): 27 30.
7. Bach, F. H.,, C. Ferran,, P. Hechenleitner,, W. Mark,, N. Koyamada,, T. Miyatake,, H. Winkler,, A. Badrichani,, D. Cardinas,, and W. H. Hancock. 1997. Accommodation of vascularized xenografts: expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nature Med. 3: 196 204.
8. Bach, F. H.,, H. Winkler,, C. Ferran,, W. W. Hancock,, and S. C. Robson. 1996. Delayed xenograft rejection. Immunol. Today 17: 379 384.
9. Blakely, M. L.,, W. J. Van Der Werf,, M. C. Berndt,, A. P. Dalmasso,, F. H. Bach,, and W. W. Hancock. 1994. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58: 1059 1066.
10. Blau, H. M.,, and M. L. Springer. 1995. Muscle-mediated gene therapy. N. Engl. J. Med. 333: 1554 1556.
11. Brauer, R. B.,, W. M. Baldwin III,, M. R. Daha,, S. K. Pruitt,, and F. Sanfilippo. 1993. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J. Immunol. 151: 7240 7248.
12. Brent, L. 1997. Clinical aspects and immunosuppression, p. 306 343. In A History of Transplantation Immunology. Academic Press, San Diego, Calif.
13. Bustos, M.,, and J. L. Platt. 1997. Platelet-endothelial cell interactions in a xenograft model. Transplant. Proc. 29: 886.
14. Bustos, M.,, S. Saadi,, and J. L. Platt. Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Submitted.
15. Byrne, G. W.,, K. R. McCurry,, M. J. Martin,, S. M. McClellan,, J. L. Platt,, and J. S. Logan. 1997. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63: 149 155.
16. Calne, R. Y.,, D. R. Davis,, J. R. Pena,, H. Balner,, M. De Vries,, B. M. Herbertson,, V. C. Joysey,, P. R. Millard,, M. J. Seaman,, J. R. Samuel,, J. Stibbe,, and D. L. Westbroek. 1970. Hepatic allografts and xenografts in primates. Lancet 1: 103 106.
17. Calne, R. Y.,, H. J. O. White,, B. M. Herbertson,, P. R. Millard,, D. R. Davis,, J. R. Salaman,, and J. R. Samuel. 1968. Pig-to-baboon liver xenografts. Lancet 1: 1176 1178.
18. Carrel, A. 1914. The transplantation of organs. N.Y. J. Med. 99: 839 840.
19. Chart, R. S.,, B. H. Collins,, J. C. Magee,, A. D. Kirk,, R. C. Harland,, R. L. McCann,, J. L. Platt,, and W. C. Meyers. 1994. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N. Engl. J. Med. 331: 234 237.
20. Chopek, M. W.,, R. L. Simmons,, and J. L. Platt. 1987. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant. Proc. 19: 4553 4557.
21. Collins, B. H.,, W. Parker,, and J. L. Platt. 1994. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation 1: 36 46.
22. Cotterell, A. H.,, B. H. Collins,, W. Parker,, R. C. Harland,, and J. L. Platt. 1995. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 60: 861 868.
23. Cozzi, E.,, and D. J. G. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1: 964 966.
24. Cozzi, E.,, N. Yannoutsos,, G. A. Langford,, G. Pino-Chavez,, J. Wallwork,, and D. J. G. White,. 1997. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs, p. 665 682. In D. K. C. Cooper,, E. Kemp,, J. L. Platt,, and D. J. G. White (ed.), Xenotransplantation: The Transplantation of Organs and Tissues Between Species, 2nd ed. Springer, Berlin, Germany.
25. Daggett, C. W.,, M. Yeatman,, A. J. Lodge,, E. P. Chen,, C. Gullotto,, M. M. Frank,, J. L. Platt,, and R. D. Davis. 1998. Total respiratory support from swine lungs in primate recipients. J. Thome. Cardiovasc. Surg. 115: 19 27.
26. Dalmasso, A. P.,, G. M. Vercellotti,, J. L. Platt,, and F. H. Bach. 1991. Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 52: 530 533.
27. Deacon, T.,, J. Schumacher,, J. Dinsmore,, C. Thomas,, P. Palmer,, S. Kott,, A. Edge,, D. Penney,, S. Kassissieh,, P. Dempsey,, and O. Isacson. 1997. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nature Med. 3: 350 353.
28. Diamond, L. E.,, K. R. McCurry,, E. R. Oldham,, S. B. McClellan,, M. J. Martin,, J. L. Platt,, and J. S. Logan. 1996. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 61: 1241 1249.
29. Edwards, J. 1981. Complement activation by xenogeneic red blood cells. Transplantation 31: 226 227.
30. Evans, R. W.,, C. E. Orians,, and N. L. Ascher. 1992. The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. J. Am. Med. Assoc. 267: 239 246.
31. Exner, B. G.,, M. Neipp,, and S. T. Ildstad. 1997. Baboon bone marrow transplantation in humans: application of cross-species disease resistance. World J. Surg. 21: 962 967.
32. Galili, U.,, M. R. Clark,, S. B. Shohet,, J. Buehler,, and B. A. Macher. 1987. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc. Nat. Acad. Sci. USA 84: 1369 1373.
33. Galili, U.,, I. Flechner,, A. Knyszynski,, D. Danon,, and E. A. Rachmilewitz. 1986. The natural anti-α-galactosyl IgG on human normal senescent red blood cells. B. J. Haematol. 62: 317 324.
34. Galili, U.,, R. E. Mandrell,, R. A. Hamadeh,, S. B. Shohet,, and J. M. Griffiss. 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56: 1730 1737.
35. Geller, R. L.,, P. Rubinstein,, and J. L. Platt. 1994. Variation in expression of porcine xenogeneic antigens. Transplantation 58: 272 277.
36. Geller, R. L.,, M. Turman,, F. H. Bach,, and J. L. Platt. 1992. Deposition of polyreactive antibodies in xenograft rejection: detection using anti-idiotype monoclonal antibodies. Transplant. Proc. 24: 595.
37. Good, A. H.,, D. K. C. Cooper,, A. J. Malcolm,, R. M. Ippolito,, E. Koren,, F. A. Neethling,, Y. Ye,, N. Zuhdi,, and L. R. Lamontagne. 1992. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. 24: 559 562.
38. Gritsch, H. A.,, R. M. Glaser,, D. W. Emery,, L. A. Lee,, C. V. Smith,, T. Sablinski,, J. S. Arn,, D. H. Sachs,, and M. Sykes. 1994. The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 57: 906 917.
39. Groth, C. G.,, O. Korsgren,, A. Tibell,, J. Tollemar,, E. Moller,, J. Bolinder,, J. Ostman,, F. P. Reinholt,, C. Hellerstrom,, and A. Andersson. 1994. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344: 1402 1404.
40. Guthrie, C. C. 1912. Blood-Vessel Surgery and Its Applications. Longmans, Green & Co., New York, N.Y.
41. Heneine, W.,, A. Tibell,, W. M. Switzer,, P. Sandstrom,, G. V. Rosales,, A. Mathews,, O. Korsgren,, L. E. Chapman,, T. M. Folks,, and C. G. Groth. 1998. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352: 695 699.
42. Holzknecht, Z. E.,, S. Coombes,, B. A. Blocher,, T. B. Plummer,, M. Bustos,, C. L. Lau,, R. D. Davis,, and J. L. Platt. Immune complex formation after xenotransplantation. Submitted.
43. Holzknecht, Z. E.,, S. Coombes,, B. A. Blocher,, T. B. Plummer,, M. Bustos,, C. L. Lau,, R. D. Davis,, and J. L. Platt. Evidence of immunocomplex formation in pulmonary xenografts. Transplant. Proc. In press.
44. Holzknecht, Z. E.,, and J. L. Platt. 1995. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J. Immunol. 154: 4565 4575.
45. Inverardi, L.,, B. Clissi,, A. L. Stolzer,, J. R. Bender,, and R. Pardi. 1996. Overlapping recognition of xenogeneic carbohydrate ligands by human natural killer lymphocytes and natural antibodies. Transplant. Proc. 28: 552.
46. Inverardi, L.,, M. Samaja,, R. Motterlini,, F. Mangili,, J. R. Bender,, and R. Pardi. 1992. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immunol. 149: 1416 1423.
47. Jaboulay, M. 1906. De reins au pli du coude par soutures arterielles et veineuses. Lyon Med. 107: 575 577.
48. Jooste, S. V.,, R. B. Colvin,, and H. J. Winn. 1981. The vascular bed as the primary target in the destruction of skin grafts by antiserum. J. Exp. Med. 154: 1332 1341.
49. Kaplon, R. J.,, R. E. Michler,, H. Xu,, P. A. Kwiatkowski,, N. M. Edwards,, and J. L. Platt. 1994. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 59: 1 6.
50. Kaplon, R. J.,, J. L. Platt,, P. A. Kwiatkowski,, N. M. Edwards,, H. Xu,, A. S. Shah,, and R. E. Michler. 1995. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation 59: 410 416.
51. Kaufman, D. B.,, J. L. Platt,, E. L. Rabe,, P. G. Stock,, and D. E. R. Sutherland. 1990. The immunological basis of islet allograft primary non-function. J. Exp. Med. 172: 291 302.
52. Kypson, A. P.,, K. Peppel,, S. A. Akhter,, R. E. Lilly,, D. D. Glower,, R. J. Lefkowitz,, and W. J. Koch. 1998. Ex vivo adenoviral-mediated gene transfer to the adult rat heart. J. Thorac. Cardiovasc. Surg. 115: 623 630.
53. Lawson, J. H.,, L. Daniels,, and J. L. Platt. 1997. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant. Proc. 29: 884 885.
54. Lawson, J. H.,, and J. L. Platt. 1996. Molecular barriers to xenotransplantation. Transplantation 62: 303 310.
55. Leventhal, J. R.,, A. J. Matas,, L. H. Sun,, S. Reif,, R. M. Bolman,, A. P. Dalmasso,, and J. L. Platt. 1993. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56: 1 8.
56. Leventhal, J. R.,, P. Sakiyalak,, J. Witson,, P. Simone,, A. J. Matas,, R. M. Bolman,, and A. P. Dalmasso. 1994. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 57: 974 978.
57. Li, H.,, C. Ricordi,, A. J. Demetris,, C. L. Kaufman,, C. Korbanic,, M. L. Hronakes,, and S. T. Ildstad. 1994. Mixed xenogeneic chimerism (mouse+rat*>mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Transplantation 57: 592 598.
58. Lin, S. S.,, D. L. Kooyman,, L. J. Daniels,, C. W. Daggett,, W. Parker,, J. H. Lawson,, C. W. Hoopes,, C. Gullotto,, L. Li,, P. Birch,, R. D. Davis,, L. E. Diamond,, J. S. Logan,, and J. L. Platt. 1997. The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant. Immunol. 5: 212 218.
59. Lin, S. S.,, and J. L. Platt. 1998. Genetic therapies for xenotransplantation. J. Am. Coll. Surg. 186: 388 396.
60. Lin, S. S.,, B. C. Weidner,, G. W. Byrne,, L. E. Diamond,, J. H. Lawson,, C. W. Hoopes,, L. J. Daniels,, C. W. Daggett,, W. Parker,, R. C. Harland,, R. D. Davis,, R. R. Bollinger,, J. S. Logan,, and J. L. Platt. 1998. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101: 1745 1756.
61. Logan, J. S.,, and M. J. Martin. 1994. Transgenic swine as a recombinant production system for human hemoglobin. Meth. Enzymol. 231: 435 445.
62. Magee, J. C.,, B. H. Collins,, R. C. Harland,, B. J. Lindman,, R. R. Bollinger,, M. M. Frank,, and J. L. Platt. 1995. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J. Clin. Invest. 96: 2404 2412.
63. Malyguine, A. M.,, S. Saadi,, R. A. Holzknecht,, C. R. Parte,, N. Sud,, J. L. Platt,, and J. R. Dawson. 1997. Induction of procoagulant function in porcine endothelial cells by human NK cells. J. Immunol. 159: 4659 4664.
64. Malyguine, A. M.,, S. Saadi,, J. L. Platt,, and J. R. Dawson. 1996. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 61: 161 164.
65. Martin, U.,, V. Kiessig,, J. H. Blusch,, A. Haverich,, K. vonderHelm,, T. Herden,, and G. Steinhoff. 1998. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 352( 9129): 692 694.
66. McCurry, K. R.,, D. L. Kooyman,, C. G. Alvarado,, A. H. Cotterell,, M. J. Martin,, J. S. Logan,, and J. L. Platt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1: 423 427.
67. McCurry, K. R.,, W. Parker,, A. H. Cotterell,, B. C. Weidner,, S. S. Lin,, L. J. Daniels,, Z. E. Holzknecht,, G. W. Byrne,, L. E. Diamond,, J. S. Logan,, and J. L. Platt. 1997. Humoral responses in pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum. Immunol. 58: 91 105.
68. Meng, X. J.,, R. H. Pureed,, P. G. Halbur,, J. R. Lehman,, D. M. Webb,, T. S. Tsareva,, J. S. Haynes,, B. J. Thacker,, and S. U. Emerson. 1997. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Nat. Acad. Sci. USA 94: 9860 9865.
69. Moses, R. D.,, H. J. Winn,, and H. Auchincloss Jr.. 1992. Multiple defects in cell surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 53: 203 209.
70. Murray, A. G.,, M. M. Khodadoust,, J. S. Pober,, and A. L. M. Bothwell. 1994. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1: 57 63.
71. Ohdan, H.,, Y.-G. Yang,, A. Shimizu,, K. G. Swenson,, and M. Sykes. 1999. Mixed bone marrow chimerism induced without lethal conditioning prevents T cell- and anti-Galα1,3Gal-mediated heart graft rejection. J. Clin. Invest. 104: 281 290.
72. Paradis, K.,, G. Langford,, Z. Long,, W. Heneine,, P. Sandstrom,, W. M. Switzer,, L. E. Chapman,, C. Lockey,, and D. Onions. 1999. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285: 1236 1241.
73. Parker, W.,, D. Bruno,, Z. E. Holzknecht,, and J. L. Platt. 1994. Xenoreactive natural antibodies: isolation and initial characterization. J. Immunol. 153: 3791 3803.
74. Parker, W.,, K. Lundberg-Swanson,, Z. E. Holzknecht,, J. Lateef,, S. A. Washburn,, S. J. Braedehoeft,, and J. L. Platt 1996. Isohemagglutinins and xenoreactive antibodies are members of a distinct family of natural antibodies. Hum. Immunol. 45: 94 104.
75. Parker, W.,, S. Saadi,, S. S. Lin,, Z. E. Holzknecht,, M. Bustos,, and J. L. Platt. 1996. Transplantation of discordant xenografts: a challenge revisited. Immunol. Today 17: 373 378.
76. Parker, W.,, P. B. Yu,, Z. E. Holzknecht,, K. Lundberg-Swanson,, R. H. Buckley,, and J. L. Platt 1997. Specificity and function of “natural” antibodies in immunodeficient subjects: clues to B-cell lineage and development. J. Clin. Immunol. 17: 311 321.
77. Patience, C.,, Y. Takeuchi,, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3: 282 286.
78. Platt, J. L. 1995. Hyperacute Xenograft Rejection. R.G. Landes, Austin, Tex.
79. Platt, J. L. 1998. New directions for organ transplantation. Nature 392( Suppl): 11 17.
80. Platt, J. L.,, R. J. Fischel,, A. J. Matas,, S. A. Reif,, R. M. Bolman,, and F. H. Bach. 1991. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52: 214 220.
81. Platt, J. L.,, T. W. LeBien,, and A. F. Michael. 1982. Interstitial mononuclear cell populations in renal graft rejection: identification by monoclonal antibodies in tissue sections. J. Exp. Med. 155: 17 30.
82. Platt, J. L.,, S. S. Lin,, and C. G. A. McGregor. 1998. Acute vascular rejection. Xenotransplantation 5: 169 175.
83. Platt, J. L.,, B. J. Lindman,, R. L. Geller,, H. J. Noreen,, J. L. Swanson,, A. P. Dalmasso,, and F. H. Bach. 1991. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 52: 1037 1043.
84. Platt, J. L.,, and J. S. Logan,. 1997. The generation and use of transgenic animals for xenotransplantation, p. 455 460. In L. M. Houdebine (ed.), Transgenic Animals: Generation and Use, 1st ed. Harwood Academic Publishers GmbH, Amsterdam, The Netherlands.
85. Platt, J. L.,, and J. S. Logan. 1996. Use of transgenic animals in xenotransplantation. Transplant. Rev. 10: 69 77.
86. Platt, J. L.,, G. M. Vercellotti,, A. P. Dalmasso,, A. J. Matas,, R. M. Bolman,, J. S. Najarian,, and F. H. Bach. 1990. Transplantation of discordant xenografts: a review of progress. Immunol. Today 11: 450 456.
87. Platt, J. L.,, G. M. Vercellotti,, B. J. Lindman,, T. R. Oegema Jr.,, F. H. Bach,, and A. P. Dalmasso. 1990. Release of heparan sulfate from endothelial cells: implications for the pathogenesis of hyperacute rejection. J. Exp. Med. 171: 1363 1368.
88. Powelson, J.,, A. B. Cosimi,, W. Austen,, M. Bailen Jr.,, R. Colvin,, P. Gianello,, T. Sablinski,, T. Lorf,, T. Kawai,, M. Tanaka,, and D. Sachs. 1994. Porcine-to-primate orthotopic liver transplantation. Transplant. Proc. 26: 1353 1354.
89. Pruitt, S. K.,, A. D. Kirk,, R. R. Bollinger,, H. C. Marsh Jr.,, B. H. Collins,, J. L. Levin,, J. R. Mault,, J. S. Heinle,, S. Ibrahim,, A. R. Rudolph,, W. M. Baldwin III,, and F. Sanfilippo. 1994. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57: 363 370.
90. Reemtsma, K.,, B. H. McCracken,, J. U. Schlegel,, M. A. Pearl,, C. W. Pearce,, C. W. DeWitt,, P. E. Smith,, R. L. Hewitt,, R. L. Flinner,, and O. Creech. 1964. Renal heterotransplantation in man. Ann. Surg. 160: 384 410.
91. Rother, R. P.,, W. L. Fodor,, J. P. Springhorn,, C. W. Birks,, E. Setter,, M. S. Sandrin,, S. P. Squinto,, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med. 182: 1345 1355.
92. Saadi, S.,, N. S. Ihrcke,, and J. L. Platt,. 1996. Pathophysiology of xenograft rejection, p. 31 45. In R. Lieberman, and R. Morris (ed.), Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity, 1st ed. Raven Press, New York, N.Y.
93. Saadi, S.,, and J. L. Platt,. 1998. Endothelial cell responses to complement activation, p. 335 353. In J. E. Volanakis, and M. M. Frank (ed.), The Human Complement System in Health and Disease. Marcel Dekker, Inc., New York, N.Y.
94. Saadi, S.,, and J. L. Platt. 1995. Transient perturbation of endothelial integrity induced by antibodies and complement. J. Exp. Med. 181: 21 31.
95. Sablinski, T.,, D. Latinne,, P. Gianello,, M. Bailin,, K. Bergen,, R. B. Colvin,, A. Foley,, H. Hong,, T. Lorf,, S. Meehan,, R. Monroy,, J. A. Powelson,, M. Sykes,, M. Tanaka,, A. B. Cosimi,, and D. H. Sachs. 1995. Xenotransplantation of pig kidneys to nonhuman primates: I. development of the model. Xenotransplantation 2: 264 270.
96. Sachs, D. H.,, and T. Sablinski. 1995. Tolerance across discordant xenogeneic barriers. Xenotransplantation 2: 234 239.
97. Sandrin, M. S.,, W. L. Fodor,, E. Mouhtouris,, N. Osman,, S. Cohney,, S. A. Rollins,, E. R. Guilmette,, E. Setter,, S. P. Squinto,, and I. McKenzie. 1995. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat. Med. 1: 1261 1267.
98. Sandrin, M. S.,, H. A. Vaughan,, P. L. Dabkowski,, and I. F. C. McKenzie. 1993. Anti-pig IgM antibodies in human serum react predominantly with Gala(l ,3)Gal epitopes. Proc. Nat. Acad. Sci. USA 90: 11391 11395.
99. Schmoeckel, M.,, F. N. K. Bhatti,, A. Zaidi,, E. Cozzi,, P. D. Waterworth,, M. J. Tolan,, M. Goddard,, R. G. Warner,, G. A. Langford,, J. J. Dunning,, J. Wallwork,, and D. J. G. White. 1998. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65: 1570 1577.
100. Selvan, R. S.,, H. B. Kapadia,, and J. L. Platt. 1998. Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J. Immunol. 161: 4388 4395.
101. Sharma, A.,, J. F. Okabe,, P. Birch,, J. L. Platt,, and J. S. Logan. 1996. Reduction in the level of Gal ( α?1,3) Gal in transgenic mice and pigs by the expression of an a( 1,2) fucosyltransferase. Proc. Nat. Acad. Sci. USA 93: 7190 7195.
102. Starzl, T. E.,, A. J. Demetris,, N. Murase,, S. Ildstad,, C. Ricordi,, and M. Trucco. 1992. Cell migration, chimerism, and graft acceptance. Lancet 339: 1579 1582.
103. Starzl, T. E.,, J. Fung,, A. Tzakis,, S. Todo,, A. J. Demetris,, I. R. Marino,, H. Doyle,, A. Zeevi,, V. Warty,, M. Michaels,, S. Kusne,, W. A. Rudert,, and M. Trucco. 1993. Baboon-to-human liver transplantation. Lancet 341: 65 71.
104. Starzl, T. E.,, T. L. Marchioro,, G. N. Peters,, C. H. Kirkpatrick,, W. E. C. Wilson,, K. A. Porter,, D. Rifkind,, D. A. Ogden,, C. R. Hitchcock,, and W. R. Waddell. 1964. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 2: 752 776.
105. Takahashi, T.,, S. Saadi,, and J. Platt. 1997. Recent advances in the immunology of xenotransplantation. Immunol. Res. 16: 273 297.
106. Ullman, E. 1914. Tissue and organ transplantation. Ann. Surg. 60: 195 219.
107. Yamada, K.,, D. H. Sachs,, and H. DerSimonian. 1995. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J. Immunol. 155: 5249 5256.
108. Yang, Y.-G.,, E. deGoma,, H. Ohdan,, J. L. Bracy,, Y. Xu,, J. Iacomini,, A. D. Thall,, and M. Sykes. 1998. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J. Exp. Med. 187: 1335 1342.
109. Ye, Y.,, F. A. Neethling,, M. Niekrasz,, E. Koren,, S. V. Richards,, M. Martin,, S. Kosanke,, R. Oriol,, and D. K. C. Cooper. 1994. Evidence that intravenously administered α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 58: 330 337.
110. Zaidi, A.,, P. Friend,, M. Schmoeckel,, F. N. K. Bhatti,, M. Tolan,, P. Waterworth,, E. Cozzi,, G. Chavez,, J. J. Dunning,, J. Wallwork,, and D. J. G. White. 1997. Hyperacute rejection is not consistent after pig to primate renal xenotransplantation (abstract). Presented at the 4th International Congress for Xenotransplantation, Nantes, France.
111. Zaidi, A.,, M. Schmoeckel,, F. Bhatti,, P. Waterworth,, M. Tolan,, E. Cozzi,, G. Chavez,, G. Langford,, S. Thiru,, J. Wallwork,, D. White,, and P. Friend. 1998. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65: 1584 1590.
112. Zehr, K. J.,, A. Herskowitz,, P. C. Lee,, P. Kumar,, A. M. Gillinov,, and W. A. Baumgartner. 1994. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 57: 900 906.
113. Zhao, Y.,, K. Swenson,, J. J. Sergio,, J. S. Arn,, D. H. Sachs,, and M. Sykes. 1996. Skin graft tolerance across a discordant xenogeneic barrier. Nature Med. 2: 1211 1216.


Generic image for table
Table 1

Xenograft classification

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1
Generic image for table
Table 2

Activation of complement via the alternative pathway on xenogeneic cells

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1
Generic image for table
Table 3

Factors implicated in the initiation of acute vascular rejection

Citation: Platt J. 2001. A Primer on Xenotransplantation, p 3-28. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch1

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error